{"id":"W4411373157","doi":"10.1016/j.ejca.2025.115584","title":"Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial","year":2025,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"National Cancer Institute; Clovis Oncology","keywords":"Placebo; Medicine; Oncology; Internal medicine; Ovarian carcinoma; Ovarian cancer; Cancer; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002070999,0.0002222707,0.001467884,0.0001708349,0.00007202221,0.000011635,0.000162442,0.00003790583,0.00004435319],"category_scores_gemma":[0.0009770832,0.0001267048,0.000969249,0.0002014824,0.000281668,0.000048037,0.00001786478,0.0001968441,6.32961e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000309907,"about_ca_system_score_gemma":0.0008634136,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002831773,"about_ca_topic_score_gemma":0.00001066315,"domain_scores_codex":[0.9965576,0.0008709829,0.001787442,0.0001955472,0.0003739587,0.0002144978],"domain_scores_gemma":[0.9958856,0.0008778197,0.001980739,0.0003165256,0.000853505,0.00008580154],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.968291,0.0006251297,0.0000243611,0.00005174297,0.0009716396,0.00003644041,0.0009184937,0.0001465937,0.002763266,0.0003570674,0.007342096,0.01847214],"study_design_scores_gemma":[0.9496714,0.003562518,0.0002090067,0.001073309,0.001062278,0.00003147728,0.000107414,0.0003381877,0.02326455,0.0001155305,0.02047179,0.00009251451],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.915264,0.009137619,0.01475525,0.01421142,0.007961934,0.009591692,0.0008102372,0.00002133103,0.02824651],"genre_scores_gemma":[0.9945258,0.0005517964,0.0007684889,0.0002430133,0.0008661792,0.00007466283,0.000005584323,0.00002485995,0.002939586],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07926182,"threshold_uncertainty_score":0.5166872,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04079906210408889,"score_gpt":0.3484937278941718,"score_spread":0.3076946657900829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}